Hip involvement in seropositive rheumatoid arthritis. Survivorship analysis with a 15-year follow-up. 1998

M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
Department of Rheumatoid Surgery and Orthopedics, Tampere University Hospital, Finland.

In a prospective survey of recent arthritis 96 patients had erosive and seropositive rheumatoid arthritis (RA). Severe radiological changes in the hipjoint (Larsen grade 3-5) were observed in 31 (32%) and acetabular protrusion in five (5%) patients 15 years after the onset of arthritis. At the end of follow-up Larsen score 0-100 of peripheral joints (p < 0.015), HAQ (p < 0.001), ESR (p < 0.001), and CRP (p < 0.01) were significantly higher in patients with hip joint destruction than in those without. Secondary amyloidosis was found in eight patients with and in three patients without hip involvement (p = 0.002). In survivorship analysis (the Larsen 0-2 grade hips) an overall predicted rate of survival was 80% after 14 years of rheumatoid arthritis. When analyzed according to HLA-B27 the rate of radiological survival for the patients with a positive test was 62% and 87% for the others (p = 0.02). In conclusion, RA patients with high number of destructive peripheral joints (Larsen score) and high ESR or CRP should be carefully monitored due to the increased risk of hip destruction.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006615 Hip The projecting part on each side of the body, formed by the side of the pelvis and the top portion of the femur. Coxa,Coxas,Hips
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid

Related Publications

M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
January 2001, Clinical and experimental rheumatology,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
February 2000, The Journal of rheumatology,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
January 2014, Clinical and experimental rheumatology,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
August 2021, Bosnian journal of basic medical sciences,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
January 2013, Scandinavian journal of rheumatology,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
January 1985, Psychotherapy and psychosomatics,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
January 1986, Scandinavian journal of rheumatology,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
December 2003, The Journal of arthroplasty,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
January 1998, Scandinavian journal of rheumatology,
M Y Lehtimäki, and H Kautiainen, and M M Hämäläinen, and M U Lehto, and M Ikävalko, and A B Repo, and H A Kotaniemi, and K Kaarela
August 1976, The Medical journal of Australia,
Copied contents to your clipboard!